Moukheibir Catherine
SEC insider (Form 3/4/5 filer). CIK 0001772130. Director at MoonLake Immunotherapeutics (MLTX) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in BOSTON, MA.
Companies Moukheibir Catherine has filed insider reports for
- MoonLake Immunotherapeutics (MLTX): Director
- IRONWOOD PHARMACEUTICALS INC (IRWD): Director
Moukheibir Catherine
CIK: 0001772130
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 17, 2026MLTX
MoonLake Immunotherapeutics
AwardDirectOption to Buy
22.2K shares- - Jun 16, 2026IRWD
IRONWOOD PHARMACEUTICALS INC
AwardDirect63.5K shares- - Jul 3, 2025MLTX
MoonLake Immunotherapeutics
ExerciseDirect23.5K shares- - Jul 3, 2025MLTX
MoonLake Immunotherapeutics
SaleDirect23.5K shares at avg. $48.79$1.1M - Jun 10, 2025IRWD
IRONWOOD PHARMACEUTICALS INC
AwardDirect45K shares- - Jun 5, 2025MLTX
MoonLake Immunotherapeutics
AwardDirectOption to Buy
6.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  MLTX MoonLake Immunotherapeutics | Award Option to Buy | 22,195 | - | - | Direct |
| Jun 16, 2026 |  IRWD IRONWOOD PHARMACEUTICALS INC | Award | 63,481 | - | $0 | Direct |
| Jul 3, 2025 | MLTX MoonLake Immunotherapeutics | Exercise | 23,500 | - | - | Direct |
| Jul 3, 2025 | MLTX MoonLake Immunotherapeutics | Sale | 23,500 | $48.79 | $1,146,565 | Direct |
| Jun 10, 2025 | IRWD IRONWOOD PHARMACEUTICALS INC | Award | 45,000 | - | - | Direct |
| Jun 5, 2025 | MLTX MoonLake Immunotherapeutics | Award Option to Buy | 6,682 | - | - | Direct |
1-6 of 6 transactions